Publications

6434 items matching your search terms.

RANK deletion in neuropeptide Y neurones attenuates oestrogen deficiency-related bone loss

Lee, N. J.; Clarke, I. M.; Zengin, A.; Enriquez, R. F.; Nagy, V.; Penninger, J. M.; Baldock, P. A.; Herzog, H.

JOURNAL OF NEUROENDOCRINOLOGY 31 (2) :e12687, 2019 10.1111/jne.12687

Pulmonary phagocyte-derived NPY controls the pathology of severe influenza virus infection

Fujiwara, S.; Hoshizaki, M.; Ichida, Y.; Lex, D.; Kuroda, E.; Ishii, K. J.; Magi, S.; Okada, M.; Takao, H.; Gandou, M.; Imai, H.; Hara, R.; Herzog, H.; Yoshimura, A.; Okamura, H.; Penninger, J. M.; Slutsky, A. S.; Uhlig, S.; Kuba, K.; Imai, Y.

Nature Microbiology 4 (2) :258-268, 2019 10.1038/s41564-018-0289-1

The proliferative and apoptotic landscape of basal-like breast cancer

Alexandrou, S.; George, S. M.; Ormandy, C. J.; Lim, E.; Oakes, S. R.; Caldon, C. E.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 20 (3) :667, 2019 10.3390/ijms20030667

Results of a Prospective Phase 2 Pilot Trial of (177)Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression

Emmett, L.; Crumbaker, M.; Ho, B.; Willowson, K.; Eu, P.; Ratnayake, L.; Epstein, R.; Blanksby, A.; Horvath, L.; Guminski, A.; Mahon, K.; Gedye, C.; Yin, C.; Stricker, P.; Joshua, A. M.

Clinical Genitourinary Cancer 17 (1) :15-22, 2019 10.1016/j.clgc.2018.09.014

Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus

Buckley, M. A.; Woods, N. T.; Tyrer, J. P.; Mendoza-Fandino, G.; Lawrenson, K.; Hazelett, D. J.; Najafabadi, H. S.; Gjyshi, A.; Carvalho, R. S.; Lyra, P. C., Jr.; Coetzee, S. G.; Shen, H. C.; Yang, A. W.; Earp, M. A.; Yoder, S. J.; Risch, H.; Chenevix-Trench, G.; Ramus, S. J.; Phelan, C. M.; Coetzee, G. A.; Noushmehr, H.; Hughes, T. R.; Sellers, T. A.; Goode, E. L.; Pharoah, P. D.; Gayther, S. A.; Monteiro, A. N. A.; Ovarian Cancer Association Consortium.

CANCER RESEARCH 79 (3) :467-481, 2019 10.1158/0008-5472.CAN-17-3864

Relieving ER stress to target NASH-driven hepatocellular carcinoma

Reibe, S.; Febbraio, M. A.

Nature Reviews Endocrinology 15 (2) :73-74, 2019 10.1038/s41574-018-0145-7

High Degree of Genetic Heterogeneity for Hereditary Cerebellar Ataxias in Australia

Kang, C.; Liang, C.; Ahmad, K. E.; Gu, Y.; Siow, S. F.; Colebatch, J. G.; Whyte, S.; Ng, K.; Cremer, P. D.; Corbett, A. J.; Davis, R. L.; Roscioli, T.; Cowley, M. J.; Park, J. S.; Sue, C. M.; Kumar, K. R.

CEREBELLUM 18 (1) :137-146, 2019 10.1007/s12311-018-0969-7

A 5alpha-reductase (SRD5A2) polymorphism is associated with serum testosterone and sex hormone-binding globulin in men, while aromatase (CYP19A1) polymorphisms are associated with oestradiol and luteinizing hormone reciprocally

Yeap, B. B.; Knuiman, M. W.; Handelsman, D. J.; Ho, K. K. Y.; Hui, J.; Divitini, M. L.; Arscott, G. M.; McQuillan, B.; Hung, J.; Beilby, J. P.

CLINICAL ENDOCRINOLOGY 90 (2) :301-311, 2019 10.1111/cen.13885

Local specific Immunoglobulin E among patients with nonallergic rhinitis: a systematic review

Hamizan, A. W.; Rimmer, J.; Husain, S.; Alvarado, R.; Tatersall, J.; Sewell, W.; Kalish, L.; Harvey, R. J.

RHINOLOGY 57 (1) :10-20, 2019 10.4193/Rhin18.074

Overcoming CDK4/6 inhibitor resistance in ER positive breast cancer

Portman, N.; Alexandrou, S.; Carson, E.; Wang, S.; Lim, E.; Caldon, C. E.

ENDOCRINE-RELATED CANCER 26 :R15-R30, 2019 10.1530/erc-18-0317

Exceptional response to 177Lutetium Prostate-Specific Membrane Antigen in prostate cancer harboring DNA repair defects

Crumbaker, Megan; Emmett, Louise; Horvath, Lisa G.; Joshua, Anthony M.

JCO Precision Oncology (3) :1-5, 2019 10.1200/po.18.00237

Postexercise skeletal muscle signaling responses to moderate- to high-intensity steady-state exercise in the fed or fasted state

Stocks, B.; Dent, J. R.; Ogden, H. B.; Zemp, M.; Philp, A.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 316 (2) :E230-E238, 2019 10.1152/ajpendo.00311.2018

Optimise not compromise: The importance of a multidisciplinary breast cancer patient pathway in the era of oncoplastic and reconstructive surgery

Strach, M. C.; Prasanna, T.; Kirova, Y. M.; Alran, S.; O'Toole, S.; Beith, J. M.; Poortmans, P.; McNeil, C. M.; Carroll, S.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 134 :10-21, 2019 10.1016/j.critrevonc.2018.11.007

Phenotypic and molecular dissection of Metaplastic Breast Cancer and the prognostic implications

McCart Reed, A. E.; Kalaw, E.; Nones, K.; Bettington, M.; Lim, M.; Bennett, J.; Johnstone, K.; Kutasovic, J. R.; Saunus, J. M.; Kazakoff, S.; Xu, Q.; Wood, S.; Holmes, O.; Leonard, C.; Reid, L. E.; Black, D.; Niland, C.; Ferguson, K.; Gresshoff, I.; Raghavendra, A.; Harvey, K.; Cooper, C.; Liu, C.; Kalinowski, L.; Reid, A. S.; Davidson, M.; Pearson, J. V.; Pathmanathan, N.; Tse, G.; Papadimos, D.; Pathmanathan, R.; Harris, G.; Yamaguchi, R.; Tan, P. H.; Fox, S.; O'Toole, S. A.; Simpson, P. T.; Waddell, N.; Lakhani, S. R.

JOURNAL OF PATHOLOGY 247 (2) :214-227, 2019 10.1002/path.5184

The Medical Genome Reference Bank: a whole-genome data resource of 4000 healthy elderly individuals. Rationale and cohort design

Lacaze, P.; Pinese, M.; Kaplan, W.; Stone, A.; Brion, M. J.; Woods, R. L.; McNamara, M.; McNeil, J. J.; Dinger, M. E.; Thomas, D. M.

EUROPEAN JOURNAL OF HUMAN GENETICS 27 (2) :308-316, 2019 10.1038/s41431-018-0279-z

Results of a prospective phase 2 pilot trial of (177)Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer including imaging predictors of treatment response and patterns of progression

Emmett, L.; Crumbaker, M.; Ho, B.; Willowson, K.; Eu, P.; Ratnayake, L.; Epstein, R.; Blanksby, A.; Horvath, L.; Guminski, A.; Mahon, K.; Gedye, C.; Yin, C.; Stricker, P.; Joshua, A. M.

Clinical Genitourinary Cancer 17 (1) :15-22, 2019 10.1016/j.clgc.2018.09.014